Lysophosphatidic Acid and its Receptors LPA and LPA Mediate Paclitaxel-Induced Neuropathic Pain in Mice
Background: Paclitaxel, which is widely used for the treatment of solid tumors, causes neuropathic pain via poorly understood mechanisms. Previously, we have demonstrated that lysophosphatidic acid (LPA) and its receptors (LPA 1 and LPA 3 ) are required for the initiation of peripheral nerve injury-...
Gardado en:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publishing
2014-11-01
|
| Series: | Molecular Pain |
| Acceso en liña: | https://doi.org/10.1186/1744-8069-10-71 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|